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Background: The aim of this study was to determine if the achievement of control targets in patients with type 2
diabetes was associated with personal socioeconomic factors and if these associations were sex-dependent.
Methods: This cross-sectional, population-based study was conducted in Spain. Glycated haemoglobin (HbA1c) level and
other clinical parameters were obtained from electronic primary care records (n= 32,638 cases). Socioeconomic status
was determined using education level and yearly income. Among patients, having their HbA1c level checked during the
previous year was considered as an indirect measure of the process of care, whereas tobacco use and clinical parameters
such as HbA1c, low-density lipoprotein cholesterol (LDL-c) and blood pressure (BP) were considered intermediate control
outcomes. General linear mixed effect models were used to assess associations.
Results: The achievement of metabolic and cardiovascular control targets in patients with type 2 diabetes was associated
with educational level and income, and socioeconomic gradients differed by sex. The probability of having had an HbA1c
test performed in the previous year was higher in patients with lower education levels. Patients in the lowest income and
education level categories were less likely to have reached the recommended HbA1c level. Males in the lowest education
level categories were less likely to be non-smokers or to have achieved the blood pressure targets. In contrast, patients
within the low income categories had a higher probability of reaching the recommended LDL-c level.
Conclusions: Our results suggest the presence of socioeconomic inequalities in the achievement of cardiovascular and
metabolic control that differed in direction and magnitude depending on the measured outcome and sex of the patient.
These findings may help health professionals focus on high-risk individuals to decrease health inequalities.
Keywords: Socioeconomic status, Socioeconomic inequalities, Diabetes mellitus, Diabetes care, Cardiometabolic risk
factors, Cardiovascular control, Metabolic control, Glycated haemoglobinBackground
Type 2 diabetes prevalence has experienced a rapid
global increase in recent decades, reaching 8.8% in
people over the age of 20 years in 2017, and is
expected to continue rising, with a projected preva-
lence of 10.4% by 2040 [1]. This chronic metabolic
condition has been associated with high morbidity
and disability, and confers an approximately two-fold* Correspondence: arkaitz.galbete.jimenez@navarra.es
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other conventional risk factors [2]. This implies an
exorbitant cost to both patients and society that
accounted for approximately 12.5% of total health
expenditures worldwide in 2017 [1]. Optimal disease
management has been recognized to lead to fewer
complications, [3, 4]. However, the achievement of
cardiometabolic risk factor control in diabetic
patients remains challenging, and the identification
of factors associated with optimal control has
become a key issue in recent literature [5–7].
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betes. It has been well recognized that having a low so-
cioeconomic status (SES), commonly measured in terms
of education, income, occupational social class or finan-
cial wealth, may be associated with a higher incidence
and prevalence of diabetes [8–10]. In patients with this
pathological condition, low SES has been shown to be
associated with mortality [11–13]. Further, according to
a recent systematic literature review [14], low individual
SES and regional deprivation were found to be fre-
quently associated with worse process and intermediate
outcome indicators in these patients. Nevertheless, some
studies did not find these associations with intermediate
outcomes [15, 16], others found associations for only
some of them, [17–20] and only a few studies assessed if
social gradients in cardiovascular risk factors differed by
gender. Although the exact mechanisms or pathways
linking socioeconomic status to health in persons with
diabetes mellitus are unknown, a conceptual framework
by Brown et al. [21], which was empirically modified and
validated by Walker et al. [22], attempted to elucidate
these associations. These authors suggested that individ-
ual features as well as contextual factors, such as com-
munities and health care organizations, influence this
association. They hypothesized that social determinants
were directly associated with diabetes-related health out-
comes, in addition to being associated with self-care, ac-
cess to care and processes of care, which are also
associated with these health outcomes.
Health inequality varies across regions and coun-
tries, and it is not merely a reflection of income
inequality [23]. Spain has relatively low - although
still significant - income-related health inequalities
compared to other European countries [23]. Citizens
are covered by the National Health Services (NHS) of
Spain, a decentralized structure administered by each
autonomous government that provides practically uni-
versal healthcare financed by general taxes, and health
services, such as hospitalizations and diagnostic pro-
cedures, are free of charge for all citizens. A fraction
of medication costs is paid for by patients within a
cost-sharing scheme established in Spain in July 2012
that is based on their employment and income status,
with some regional variations [24]. In spite of the
relatively low health inequality in Spain, there exists a
substantial contribution of regional health disparities
on the socioeconomic inequalities of the country [23,
25], with northern regions such as Basque Country,
Navarre and La Rioja presenting the lowest degree of
these inequalities [25]. The monitoring of health in-
equalities has been officially included in the political
agenda in Spain [26], but research assessing the im-
pact of SES on intermediate outcomes for chronic
diseases in the country is still scarce [27].This work aimed to assess the extent to which SES,
measured at the individual level, is a determinant of the
achievement of control of metabolic/cardiovascular risk
factors in patients with type 2 diabetes in one of the re-
gions of Spain with the lowest health inequality, and
whether this association differs between women and
men.
Methods
This population-based cross-sectional study was con-
ducted in Navarre, an autonomous region in northern
Spain with more than 600,000 inhabitants. In this region,
citizens are covered by the Regional Health Service of
Navarre – Osasunbidea, which is part of the NHS of
Spain. They are commonly served by one primary care
centre with a stable team of general practitioners,
nurses, paediatricians and other healthcare workers, and
only 3.2% of the population has private or mixed health
insurance [28].
Two sources of information were available for use in
this study. The Primary Care Electronic Medical Record
System of the Regional Health Service of Navarre,
named Atenea, was used to identify patients with dia-
betes and to obtain their demographic and clinical data.
This system was established in the early 2000s and has
been comprehensively used by all health professionals
since 2008. It contains diagnosis, clinical, lifestyle,
laboratory results, and prescription data. Additionally,
the 2013 population register was used to obtain the
educational level of the patients. All patients over
20 years of age registered in Atenea with a diagnosis of
type 2 diabetes (code T90 within the International Clas-
sification of Primary Care) on May 15, 2014 were in-
cluded in this study. The extraction of data from
Atenea records was conducted by the Department of
Informatics, Telecommunication and Public Innovation
of the Government of Navarre (DGITIP) using the SQL
Server Integration Services Platform, and was linked
with the population register by the Institute of Statistics
of Navarre. Of a total of 33,346 patients with an active
code of type 2 diagnosis, 693 (2.1%) had no clinical his-
tory record number or individual identification code,
and 15 were excluded for being < 20 years old, resulting
in a working sample of 32,638 patients. Regarding
population data, of the total of 33,346 patients, 31,792
(95.3%) were linked with the individual patient identifi-
cation code, 1044 (3.1%) with the identity card and 25
(0.1%) using name and birth data, and the remaining
485 (1.5%) could not be found in the population regis-
ter and were missing for the educational level variable.
The linked dataset with 32,638 patients was anon-
ymized before transfer to the researchers.
Data from laboratory test results, including the gly-
cated haemoglobin (HbA1c) level; systolic and diastolic
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cholesterol and triglyceride levels; and demographic and
clinical data, such as weight, height, body mass index
(BMI), smoking status (current smoker versus not
current smoker), medication use, date of registration in
the information system, date of diabetic onset and birth
date, were included in this study. We used the latest data
available within the 15 months prior to the data extrac-
tion date. Having at least one measurement of HbA1c
within the previous year was considered an indirect indi-
cator of the process of care [11]. To assess the achieve-
ment of control objectives, the following thresholds were
used: HbA1c level < 7% (53 mmol/mol), blood pressure ≤
140/90 mmHg, LDL-cholesterol level ≤ 100 mg/dl and
no tobacco consumption.
We considered education and copayment level, the
latter used as a proxy of income, as indicators of socio-
economic status. Education level was aggregated
according to four levels: unfinished primary education,
primary education, secondary education (high school)
and college (and above) education. The copayment
level, the coinsurance status of the patients that deter-
mines the percentage of the price of the drug to be paid
by the patient, is assigned to each insured person based
on his/her annual income and pensioner status (pen-
sioner or non-pensioner). Three categories were
created for this study: yearly income < 18,000 €, yearly
income ≥18,000 €, and those who were excluded or
exempted for payment, which included people who
were unemployed without benefits; were receiving the
minimum subsistence income; had been diagnosed with
a toxic syndrome, certain disabilities, work-related acci-
dents or occupational disease; or were pensioners with
non-contributory retirement pensions.
Statistical analysis
Patient characteristics and the achievement of control
targets were summarized using frequencies and percent-
ages. To examine the relationship between educational
level and each of the control target criteria, a mixed
effects logistic regression model with complete cases for
each target criteria was fitted. The models included edu-
cational level as exposure variable age (continuous) and
sex as control variables, and basic health zone as
random effects, to account for any variability between
zones. The same model structure was used to examine
the relationship between income level and each control
target criterion. The highest level of study and the
highest level of income were considered the reference
categories. Specific models for males and females were
also fitted to assess gender-specific social gradients, and
they were used for interpretation purposes when interac-
tions between sex and SES variables were significant at
p < 0.05. Complementary, specific models for pensionersand non-pensioners were fitted, and the results of
these models are displayed as footnotes only for the
two models for which the interaction between SES
and pensioner status was significant. Variable signifi-
cance was determined using the likelihood ratio test,
and adjusted odds ratios with 95% confidence inter-
vals were derived for each fitted model. All statistical
analyses were performed using the statistical package
R, version 3.2.0.
Results
In total, 32,638 patients over 20 years of age with type 2
diabetes were registered in the Navarre Regional Health
Service, and 679 of them (2%) had been diagnosed
within the last year. The sociodemographic characteris-
tics of the patients and the proportion of patients not
achieving control targets are given in Table 1. The per-
centage of non-missing data was over 95% for all socio-
demographic characteristics and over 70% for all
indicators of disease control considered except for
tobacco use, which was 38%. Of the patients, 56% were
men, 70% were aged 65 years or older and 73% were
pensioners. Most of the patients belonged to the lowest
income categories of copayment (69% had income <
18,000 € and 4% were excluded or exempted for pay-
ment), and more than half (53%) had a primary level of
education.
Guideline compliance results showed that the target
achievement varied based on the assessed criterion. The
criterion of having had ‘at least one basic laboratory test
including HbA1c levels performed during the previous
year’, as an indicator of adequate adherence to clinical
practice, was achieved in 71% of the diabetic patients
and was more frequently identified in patients over the
age of 65 years (74%), pensioners (74%), and patients
with lower education levels (73%). Failure to achieve
control targets was observed in a high proportion of
patients, as demonstrated by the LDL level > 100 mg/dl
(59%), HbA1c level > 7% (40%) and BP > 140/90 mmHg
criteria (30%). Approximately 16% of the patients were
registered as smokers, and this proportion increased to
21% in men and 31% in those < 65 years old. An assess-
ment of sex and age differences in the achievement of
control targets in this population can be found in
Cambra et al. [29].
Associations between SES indicators and regular HbA1c
measurement
Education level was found to be associated with the eval-
uated medical process measure (see first column in
Table 2). Patients with lower educational level were
more frequently identified as having had a basic labora-
tory test conducted during the previous year, and this
gradient was significantly steeper in females than in
Table 1 Descriptive characteristics of the sample and fulfilment of target criteria
Characteristics N availablea Control previous
Year (%)b
Unachieved targets (%)c
HbA1c > 7% LDL > 100 mg/dl BP > 140/90 mmHg Current smoker
(n = 32,638) (n = 32,638) (n = 23,094) (n = 23,891) (n = 24,595) (n = 12,413)
Age 32,638(100%) 70.8 39.9 59.5 30.1 16.0
< 65 years 10,803(33.1%) 64.3 41.5 64.6 26.5 30.9
≥ 65 years 21,835(66.9%) 73.9 39.2 57.4 31.5 9.9
Sex 32,206(98.7%) 71.2 39.9 59.5 30.1 16.0
Men 18,188(56.5%) 70.9 38.8 55.3 30.0 21.3
Women 14,018(43.5%) 71.6 41.2 64.8 30.3 8.8
Pensioner situation 32,638(100%) 70.8 39.9 59.5 30.1 16.0
Non-pensioner 8838 (27.1%) 63.1 41.7 66.2 28.0 29.6
Pensioner 23,800 (72.9%) 73.7 39.3 57.4 30.7 11.9
Education level 32,060(98.2%) 71.3 39.8 59.5 30.1 16.0
College education 1655(5.2%) 63.1 33.2 59.5 28.8 17.0
Secondary education 3056(9.5%) 65.8 36.7 60.8 28.6 24.7
Primary education 16,869(52.6%) 72.2 40.0 60.1 30.0 17.0
Without primary education 10,480(32.7%) 72.6 41.3 58.2 30.7 11.9
Income 31,709 (97.2%) 70.9 39.8 59.5 30.1 16.0
≥ 18,000 € 8372 (26.4%) 72.5 36.5 60.6 29.4 19.6
< 18,000 € 21,95,269.2%) 70.4 41.0 59.0 30.3 14.2
Excluded/exempted 1385 (4.4%) 70.6 42.2 61.6 31.5 23.2
aN available: Number of patients and percentage of data available for each variable and number and percentage of patients in each category
bControl previous year: Percentage of patients with HbA1c data within the past 15 months
cUnachieved targets: Percentage of patients within each category that did not reach the current local control targets for each risk factor
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women with a lower education level had two-fold
greater odds of testing; whereas in men, the odds were
1.2-fold greater.
Income was also associated with the probability of
having had a test performed within the past year; how-
ever, significantly different gradients were identified in
non-pensioners and pensioners and in men and women
(see first column in Table 3 and footnote c). In female
non-pensioners, those excluded from payment and those
in the low-income category had significantly greater
odds of having had a test performed than those in the
high income category (OR = 1.71 and OR = 1.37 respect-
ively p < 0.001). In male pensioners, however, an inverse
gradient was observed, and patients in the lowest
income categories were significantly less likely to have
had a test performed.
Associations between SES indicators and glycaemic
control
Patients with lower education levels had higher odds of
not meeting HbA1c targets, and the gradient was steeper
in women. For women, the odds of noncompliance were
approximately twice as high for those with primary edu-
cation or without education than for those with auniversity education, whereas in males, the odds were
close to 1.2 times as high (see Table 2).
The association between income and glycaemic con-
trol was significant, and the gradients did not differ sig-
nificantly by sex or pensioner status. Greater odds of
noncompliance were identified in patients within the
low-income and excluded categories than those within
the high-income category, with an estimated magnitude
of approximately 1.20 in both cases (Table 3).
Associations between SES indicators and cardiovascular
risk factors
Education level was not significantly associated with
LDL compliance; however, education was significantly
associated with tobacco use and marginally associated
with BP targets, specifically in males. Compared to male
patients with a university education, those with lower
levels of education had approximately 20% greater odds
of not meeting BP targets and approximately 40%
greater odds of being smokers. In contrast, female
patients without a university education had approxi-
mately 36% lower odds of being tobacco users than
females with a university education (Table 2).
Patients in the low-income categories were more likely
to achieve the recommended LDL targets than those in
Table 2 Age- and sex-adjusted and sex-specific logistic regression model results for the failure to achieve control targets by
educational level
Control previous yeara Unachieved targetsb
HbA1c > 7% LDL > 100 mg/dl BP > 140/90 mmHg Current smoker
OR (95% CI) P OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Total sample
Sex
Men Reference Reference Reference Reference Reference
Women 0.95(0.91,1.00) 0.068 1.11(1.05,1.17) < 0.001 1.62(1.54,1.72) < 0.001 0.96(0.91,1.02) 0.219 0.43(0.38,0.49) < 0.001
Education level
University Reference Reference Reference Reference Reference
Secondary 1.20(1.06,1.37) < 0.001c 1.12(0.96,1.32) < 0.001c 0.99(0.85,1.16) 0.576 1.09(0.92,1.29) 0.753c 1.37(1.05,1.80) 0.008c
Primary 1.52(1.36,1.70) 1.27(1.11,1.46) 0.99(0.87,1.13) 1.08(0.94,1.26) 1.32(1.05,1.68)
Without 1.47(1.30,1.65) 1.34(1.16,1.55) 0.95(0.83,1.09) 1.08(0.93,1.26) 1.12(0.87,1.45)
Males
University Reference Reference Reference Reference Reference
Secondary 1.18(1.01,1.38) < 0.001 1.00(0.83,1.20) 0.004 0.99(0.83,1.19) 0.976 1.22(1.00,1.50) 0.085 1.48(1.09,2.01) 0.052
Primary 1.38(1.20,1.58) 1.10(0.94,1.29) 1.02(0.87,1.19) 1.25(1.05,1.49) 1.44(1.10,1.90)
Without 1.24(1.07,1.43) 1.23(1.04,1.46) 1.01(0.86,1.20) 1.19(0.99,1.44) 1.36(1.03,1.82)
Females
University Reference Reference Reference Reference Reference
Secondary 1.20(0.94,1.52) < 0.001 1.59(1.15,2.23) < 0.001 0.94(0.68,1.31) 0.079 0.74(0.53,1.02) 0.153 1.16(0.86,1.56) 0.001
Primary 1.91(1.56,2.33) 2.00(1.52,2.66) 0.85(0.65,1,11) 0.74(0.57,0.98) 1.00(0.77,1.28)
Without 1.99(1.62,2.45) 1.98(1.50,2.65) 0.78(0.59,1.03) 0.78(0.59,1.02) 0.64(0.49,0.83)
All models were adjusted by age (continuous) and basic health zone (random effect), resulting in significant p-values for both in all cases
aControl previous year: Response variable is 'To have HbA1c data within the past 15 months'
bUnachieved targets: Response variable for each risk factor is 'Not to have reached current local targets'
cInteraction between educational level and c sex was significant
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egory had 16% greater odds of not meeting BP targets,
and pensioner patients in this category had two-fold
greater odds of being smokers (Table 3).Discussion
In this large population-based study including people
with type 2 diabetes, we found that socioeconomic
status was associated with metabolic and cardiovascu-
lar control target achievement and that socioeconomic
gradients were not the same in men and women for
all control factors. Patients with low SES were more
likely to have had an HbA1c test performed in the
previous year, except for pensioner males, and were
less likely to have reached the recommended HbA1c
level. Regarding cardiovascular risk factors, males in
the lowest SES categories had lower odds of having
reached the BP and tobacco targets, which was in
contrast with the LDL results because patients in the
low SES categories were more likely to have achieved
the LDL target.The higher probability of having had at least one
measurement of HbA1c in the previous year in patients
within the lowest education levels was identified in
both sexes, with a more marked gradient observed in
women. These results are in agreement with other
studies conducted in Spain [30] and other European re-
gions [31], but not with others conducted further afield
[14, 32]. Our findings are probably related to the fact
that people in the lowest socioeconomic positions in
Spain are more likely to visit general practitioners than
those in the highest position [30, 33], even when taking
into account need for care [34]. Additionally, citizens in
high socioeconomic positions make more frequent use
of private services, [33] and could therefore have had
the HbA1c test done without being registered in the
Atenea records. However, it does not completely ex-
plain our findings since, in Navarre, the proportion of
people using private or mixed health insurance is only
3.2% [28], which is much lower than the differential in
the percentage of patients with the test done across
educational levels (9.5%). Interestingly, this apparent
protective effect identified in patients with low SES was
Table 3 Age- and sex-adjusted and sex-specific logistic regression model results for the failure to achieve control targets by income
category
Control previous yeara Unachieved targetsb
HbA1c > 7% LDL > 100 mg/dl BP > 140/90 mmHg Tobacco use
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Total
≥ 18.000 € Reference Reference Reference Reference Reference
< 18.000 € 0.89(0.83,0.94) < 0.001c 1.19(1.12,1.27) < 0.001 0.90(0.85,0.96) 0.004 1.00(0.94,1.08) 0.119 0.98(0.88,1.10) 0.375d
Excluded 1.01(0.89,1.15) 1.19(1.04,1.37) 0.86(0.74,0.99) 1.16(1.00,1.34) 1.17(0.91,1.50)
Males
≥ 18.000 € Reference Reference
< 18.000 € 0.80(0.75,0.86) < 0.001 1.22(1.13,1.32) < 0.001 0.89(0.82,0.96) < 0.001 0.99(0.91,1.07) 0.126 1.02(0.90,1.16) 0.385
Excluded 0.93(0.77,1.12) 1.27(1.03,1.56) 0.73(0.59,0.90) 1.24(0.99,1.54) 1.25(0.91,1.72)
Females
≥ 18.000 € Reference Reference
< 18.000 € 1.09(0.98, 1.22) 0.086 1.14(1.01,1.28) 0.102 0.93(0.82,1.05) 0.425 1.05(0.93,1.19) 0.442 0.82(0.64,1.08) 0.339
Excluded 1.22(1.01,1.47) 1.11(0.91,1.36) 1.00(0.81,1.23) 1.15(0.93,1.41) 0.92(0.60,1.40)
All models were adjusted by age (continuous) and basic health zone (random effect), resulting significant p-values for both in all cases
aControl previous year: Response variable is 'To have HbA1c data within the past 15 months'
bUnachieved targets: Response variable for each risk factor is 'Not to have reached current local targets'
cInteraction between income and sex was significant, and interaction between income and pensioner status was significant:
OR for non-pensioners: in males, category ‘< 18,000 €’ 0.93(0.81, 1.04); category excluded 1.19(0.96, 1.48); in females, category ‘< 18,000 €’ 1.37(1.11, 1.69), excluded
1.71(1.28, 2.29)
OR for pensioners: in males, category ‘< 18,000 €’ 0.76(0.70, 0.84); category excluded 0.58(0.39, 0.88); in females, category ‘< 18,000 €’ 1.07(0.94, 1.21), excluded
1.04(0.80, 1.35)
dInteraction between income and pensioner status significant. OR for non pensioners: category ‘< 18.000 €’ 1.10(0.91, 1.33), excluded 1.01(0.75,1.35), OR for
pensioners: category ‘< 18,000 €’ 0.97(0.84, 1.13), excluded 1.85(1.11, 2.96)
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likely to have had the test conducted. To interpret this
result, we should take into account the fact that
patients with diabetes-related complications could be
referred to specialized services for follow-up, and could
therefore have their HbA1c measured out of the pri-
mary care setting, without being registered in Atenea.
Referrals to specialized services could have been more
frequent in patients with low SES, as they have a lower
degree of HbA1c control, which could have induced an
overestimation of this reverse gradient. Given the rele-
vance of equity in access on health outcomes [21], this
question needs further attention.
Our finding that individuals with the lowest income
and education levels were less likely to have reached
the recommended HbA1c control targets is in line
with previous research. A review on the topic carried
out by Grintsova et al. [14] showed that, out of 18
studies examining the association between HbA1c and
SES (10 at the area level and 8 at the individual level),
11 studies identified a significant association, 6 studies
identified a statistically non-significant association in
the same direction, and only one study did not show
any difference between deprivation groups. In our
study, the gradient associated with education level was
steeper in women. These result seem to correspondwith the results of other European studies, such as a
study carried out in Sweden [35], in which the crude
risk of reaching HbA1c target levels in patients with
higher education levels was also twice that of patients
with lower educational levels in women and approxi-
mately 1.5 times greater in men. A recent review of sex
and gender differences in the risk and complications of
type 2 diabetes mellitus [36] suggested that the stron-
ger associations between SES indicators, abdominal
obesity and physical activity observed in women than
in men may be behind the apparently greater sensitiv-
ity to socio-contextual predictors often observed in
women; however, more studies are needed to clarify
this complex issue.
The association between SES and achievement of BP
targets observed in this study was marginal. The higher
level of optimal BP control observed in patients with
high study levels, especially in males, is in agreement
with the results of studies carried out in Europe [37] and
the US [20] in patients with diabetes, and is also in line
with one study conducted in Spain in the general popu-
lation [27]. However, the results have not been conclu-
sive, neither in our work nor in the aforementioned
review [14], where only one of the five studies evaluating
this association in patients with diabetes found a signifi-
cant association between BP and SES.
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consumption and low education levels in males also cor-
respond with previous studies specific to patients with
diabetes [20, 38] and are concordant with results
observed from the general population [39]. The fact that
women with diabetes and low education levels were less
frequently tobacco users was also identified in neigh-
bouring regions, such as the Basque country [30], but
not in other European countries such as Scotland, where
the risk of smoking in patients with low SES was higher
regardless of sex [38]. To reduce this social inequality,
targeted preventive and cessation programmes directed
more strongly at people belonging to lower social classes
are needed [39], since more general policies regulating
tobacco consumption, such as Spanish Law 28/2005,
have been shown to be more effective in individuals
belonging to higher social classes [40].
We did not identify an association between educa-
tional level and lipid control; however, low income was
unexpectedly associated with better LDL results. This
somewhat contrasts with the results of other research
studies included in the review by Grintsova et al. [14],
which found no significant association between SES and
lipid control in seven of the nine studies conducted at
the individual- level and a significant but inverse associ-
ation in the other two studies. We identified only two
other studies including patients with diabetes with
results in line with those of our study: a study carried
out in the US found that patients with high education
levels were less likely to have good cholesterol control
[20], and a recent study also conducted in the US [41]
suggested that employment was associated with higher
LDL levels. We could not determine the reasons for this
finding; however, it deserves to be noted that our region
is fairly rural and has strong links to agriculture and a
Mediterranean diet that is widespread in its adoption.
Considering that adherence to a Mediterranean dietary
pattern is not affected by educational status in the gen-
eral population in Spain [42] and that daily cholesterol
intake is higher in those with higher educational levels
in similar Mediterranean regions of Spain [43], our
results may not be unexpected.
Our work corroborates the influence of socioeconomic
position on intermediate health outcomes in patients
with diabetes, even in a region with one of the lowest
health inequality levels of Spain [25], a country that, in
turn, has relatively low health inequality compared to
other European countries [23]. Apart from SES-related
individual characteristics that could favour results in pa-
tients with higher SES, such as healthy diet [44, 45],
physical activity [46], medication adherence [47], social
support [44, 46] or self-efficacy [48], there are also con-
textual factors, such as the way health care institutions
are organized and the health policies they adopt, thatcould differentially affect patients according to their SES
level [21]. This differential influence may occur even in
health care systems that provide universal coverage, such
as the Spanish health system, where some organizational
barriers, such as copayments, may pose greater obstacles
for people of lower SES [21, 24]. Hence, accounting for
socioeconomic status is recommended when designing
action plans aiming at reducing adverse health out-
comes, since these programmes are likely to be more
effective if they target those with low socioeconomic
status, as they are at higher risk of worse health out-
comes. In an era where the need for more individualized
management for patients with diabetes has been jointly
stated by the European Association for the Study of
Diabetes and the American Diabetes Association to
overcome the highly standardized diabetes protocols
[49], the incorporation of socioeconomic dimensions in
addition to health variables could also help to improve
health results.
The main strength of this work was that it used data
from the real medical practice of all patients diagnosed
in this region and encompassed all age ranges, comor-
bidities and social conditions identified in the population
attended by the Regional Health Service, which accounts
for 96% of the entire population in the region. Another
strength is that we were able to link clinical data from
individual patients to demographic and socioeconomic
data from the population registers. Data on education
level and copayment level were highly complete, with
less than 2% and 3% of missing data respectively. These
two individual-level measures of SES are more robust
than other indirect or aggregated measures. Among the
limitations, it is possible for a bias resulting from the use
of existing electronic clinical records to have impacted
this study, which may be particularly important in vari-
ables for which data completeness was more dependent
on the physicians’ reporting procedures, such as tobacco
use. Second, other important factors, such as physical in-
activity, body mass index or time since diagnosis were
not been included in this analysis because they were
insufficiently reported in the clinical records. Finally, the
main source of information was the primary care elec-
tronic medical record system; thus, data from patients
who have moved away from Navarre, data from patients
followed in specialist services and data from patients re-
ceiving care in private health centres were not included
in this study, which could have specially influenced on
the results regarding the probability of having a regular
HbA1c measurement.
Conclusions
In summary, we found the presence of socioeconomic
inequalities in the achievement of control targets in
type 2 diabetic patients and identified population
Ibáñez et al. BMC Public Health  (2018) 18:408 Page 8 of 9groups that should be targeted by interventions devel-
oped to reduce these health inequalities and potentially
improve the rates of achievement of these control tar-
gets. These interventions should take into account the
multifaceted nature of the influence of socioeconomic
factors on glycaemic control and other cardiovascular
risk factors and the differential gradients observed
between males and females and between pensioners
and non-pensioners. It would also be recommended to
develop tools to incorporate information regarding
socioeconomic status and other social determinants
into the electronic clinical records to enable healthcare
professionals to take them into consideration during
daily clinical practice.
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